Avadel Pharmaceuticals Plc (AVDL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AVDL? Forum Prognose

Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	29.74% 68.13	52.51	50.02	41.50	27.18
Cost Of Revenue	14.15% 6.366	5.577	6.155	2.788	1.522
Gross Profit	31.60% 61.76	46.93	43.87	38.72	25.66
Operating Expenses	5.90% 52.88	49.94	44.20	51.46	51.69
Benefits Costs and Expenses	7.46% 61.63	57.35	52.56	55.84	54.43
Costs And Expenses	7.46% 61.63	57.35	52.56	55.84	54.43
Depreciation and Amortization	29.45% 1.068	0.825	1.035	0.437	0.541
Operating Income/Loss	396.03% 8.884	-3.001	-0.327	-12.74	-26.04
Income/Loss From Continuing Operations Before Tax	234.14% 6.495	-4.842	-2.537	-14.33	-27.25
Income Tax Expense/Benefit	4,164% -3.17	0.078	0.088	-0.509	0.093
Income/Loss From Continuing Operations After Tax	296.44% 9.665	-4.92	-2.625	-13.82	-27.34
Net Income/Loss	296.44% 9.665	-4.92	-2.625	-13.82	-27.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.13% 96.73	96.60	96.30	96.15	91.69
Diluted Average Shares	2.57% 99.09	96.60	96.30	96.15	91.69
Basic Earnings Per Share	300.00% 0.10	-0.05	-0.03	-0.14	-0.30
Diluted Earnings Per Share	300.00% 0.10	-0.05	-0.03	-0.14	-0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$28.92

3.60%

ELAN

$17.47

0.69%

RDY

$14.15

0.28%

VTRS

$10.33

2.09%

NBIX

$140.40

3.15%

UTHR

$380.47

2.80%